Abstract
Favorable Outcomes in Severe Aplastic Anemia Patients Undergoing Allo-HSCT with Fludarabine, Cyclophosphamide, and ATG Conditioning
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.jtct.2023.12.206
Journal: Transplantation and Cellular Therapy | Publication Date: Feb 1, 2024 |
Favorable Outcomes in Severe Aplastic Anemia Patients Undergoing Allo-HSCT with Fludarabine, Cyclophosphamide, and ATG Conditioning
Join us for a 30 min session where you can share your feedback and ask us any queries you have